Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (141-150 of 293) with videos related to

Pageof 30
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2010
Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovaryE Chuang, N Wiener, P Christos, et al.
Leukemia & Lymphoma|July 1, 1994
Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimenJ A Sparano, P H Wiernik, M Strack, et al.
NPJ Breast Cancer|January 23, 2018
E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancerSri Lakshmi Hyndavi Yeruva, Fengmin Zhao, Kathy D Miller, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 5, 2000
Cell-cycle dysregulation in breast cancer: breast cancer therapies targeting the cell cycleB T Zafonte, J Hulit, D F Amanatullah, et al.
American Heart Journal|November 5, 1997
Relation between injections before 90-minute angiography and coronary patency: results of the thrombolysis in myocardial infarction 4 trialC M Gibson, S J Marble, M J Rizzo, et al.
Journal of the National Cancer Institute|August 12, 2025
Ambient air pollution and mortality in older breast cancer patientsYaguang Wei, Edgar Castro, Kanhua Yin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphomaJ A Sparano, P H Wiernik, X Hu, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 31, 2012
Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patientsEugene J Fine, C J Segal-Isaacson, Richard D Feinman, et al.
Scientific Reports|July 11, 2025
CD20-bearing extracellular vesicles are associated with prognostic biomarkers of patients with AIDS-NHLLaura E Martínez, Shelly Lensing, Di Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494)Joseph A Sparano, Sandra Lee, Michael G Chen, et al.
Pageof 30

Showing results (141-150 of 293) with videos related to

Sort By:
Pageof 30
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2010
Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovaryE Chuang, N Wiener, P Christos, et al.
Leukemia & Lymphoma|July 1, 1994
Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimenJ A Sparano, P H Wiernik, M Strack, et al.
NPJ Breast Cancer|January 23, 2018
E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancerSri Lakshmi Hyndavi Yeruva, Fengmin Zhao, Kathy D Miller, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 5, 2000
Cell-cycle dysregulation in breast cancer: breast cancer therapies targeting the cell cycleB T Zafonte, J Hulit, D F Amanatullah, et al.
American Heart Journal|November 5, 1997
Relation between injections before 90-minute angiography and coronary patency: results of the thrombolysis in myocardial infarction 4 trialC M Gibson, S J Marble, M J Rizzo, et al.
Journal of the National Cancer Institute|August 12, 2025
Ambient air pollution and mortality in older breast cancer patientsYaguang Wei, Edgar Castro, Kanhua Yin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphomaJ A Sparano, P H Wiernik, X Hu, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 31, 2012
Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patientsEugene J Fine, C J Segal-Isaacson, Richard D Feinman, et al.
Scientific Reports|July 11, 2025
CD20-bearing extracellular vesicles are associated with prognostic biomarkers of patients with AIDS-NHLLaura E Martínez, Shelly Lensing, Di Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494)Joseph A Sparano, Sandra Lee, Michael G Chen, et al.
Pageof 30